Upgrade to SI Premium - Free Trial

Roivant Sciences (ROIV) PT Raised to $36 at Guggenheim

May 26, 2026 6:38 AM
Guggenheim analyst Yastin Suneja raised ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change